Since 2001, Mike Simpson has been a group leader for the Nanofabrication Research Laboratory and theme leader in the Center for Nanophase Materials Sciences. His research focus includes noise biology, nano-enabled synthetic biology and controlled synthesis and directed assembly of carbon nanostructures.
Filter Corporate Fellows
Corporate Fellow Type
Year
- (-) 2014 (1)
- (-) 2010 (1)
- (-) 2009 (1)
- (-) 2005 (2)
- (-) 2003 (1)
- (-) 2002 (1)
- (-) 1996 (2)
- (-) 1987 (1)
- (-) 1983 (1)
- (-) 1979 (4)
- 2022 (1)
- 2020 (1)
- 2016 (2)
- 2015 (2)
- 2008 (1)
- 2007 (1)
- 2006 (1)
- 2004 (1)
- 2001 (1)
- 1999 (1)
- 1998 (1)
- 1997 (2)
- 1994 (2)
- 1992 (1)
- 1990 (1)
- 1989 (1)
- 1988 (1)
- 1986 (1)
- 1985 (2)
- 1976 (2)
All Corporate Fellow summaries reflect the awardee and ORNL at the time the fellowship was awarded.
2014
2010
For his pioneering research in atom probe field-ion microscopy and atom probe tomography, most recently to understand the unprecedented properties and behaviors of nanostructured ferritic steels.
2009
For contributions to the methodology for electronic structure calculations and in applications to diverse classes of materials.
2005
For studies of the electronic structure of molecules, computational chemistry, and high-performance algorithms and computing.
For developments in biomedical engineering and biotechnology, micromechanical devices, and nanoscale imaging and detection.
2003
For outstanding contributions to the field of applied computer vision research and development that address important national interests in industrial and economic competitiveness, biomedical measurement science, and national security.
2002
For forefront studies of the fundamental science of actinide elements, through mendelevium, which employ novel experimental techniques, make systematic comparisons, and emphasize the role of the elements' electronic configurations.
1996
For development of Z-contrast microscopy, which allows the direct imaging of materials at the atomic scale.
For distinguished research in the field of risk assessment, including pharmacokinetic and pharmacodynamic models, interspecies extrapolation, and human exposure to dioxin and other background contaminants, and for significant contributions to environmental policy through pioneering investigations of the effectiveness of remediation technologies and through service on national and international advisory panels and boards
1987
For fundamental studies in radiation physics and dosimetry, in research to link the basic physics and chemistry of biological molecules irradiated in aqueous solution, and the physicochemical characterization of chemical pollutants